Furthermore, our meta-analysis has so far focused on one polymorphism from ESR1. The analyses of more polymorphisms of ESR1 in future, either individually or in tandem, may further reveal the synergistic effects of such polymorphisms in influencing BC susceptibility70. This evidence concerns the gene ESR1 and breast cancer.